Publications

5600 Results

Dose intensity is not associated with subsequent survival after adjustment for known prognostic factors in non-Hodgkin's lymphoma patients treated with m-BACOD, ProMace-CytaBOM, and MACOP-B on Southwest Oncology Group study.

Authors
S Dahlberg;TP Miller;B Dana;J Weick;RI Fisher
Journal / Conference
ASCO 9:225(#986)
Year
1990
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8410, SWOG-8503, SWOG-8508

Assessment of treatment costs for carboplatin and cisplatin.

Authors
E Hannigan;D Alberts;S Green;R O'Toole;N Mason-Liddil;E Surwit;D Stock-Novack;R Goldberg;V Malviya;W Nahhas;R Canetta;R Thomas
Journal / Conference
ASCO 9:337(#1305)
Year
1990
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

Relationship between serum CA-125 levels at chemotherapy courses 3 and 6 and the outcome of second-look surgery status in advanced ovarian cancer.

Authors
DS Alberts;PY Liu;E Hannigan;EA Surwit;J O'Sullivan;D Garcia;M Richardson;S Williams;J Young;R O'Toole
Journal / Conference
AACR 31:189(#1121)
Year
1990
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

Evaluation of "complete androgen blockade" (CAB) with flutamide (F) added to leuprolide (L) after progression on leuprolide (L) alone: Results of INT-0036 study in stage D2 cancer of the prostate (CP).

Authors
D McLeod;B Blumenstein;M Eisenberger;ED Crawford;D Spicer;J Spaulding;A Dorr;R Benson
Journal / Conference
ASCO 9:136(#526)
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8494 (INT-0036)

Intra-arterial cisplatin and radiation therapy in the management of high grade gliomas - results of SWOG-8510.

Authors
JE Mortimer;J Crowley
Journal / Conference
ASCO 9:90(#352)
Year
1990
Research Committee(s)
Brain
Study Number(s)
SWOG-8510

Advanced bladder cancer: A prospective intergroup trial comparing single agent cisplatin (CDDP) vs. M-VAC combination therapy (INT-0078).

Authors
PJ Loehrer;P Elson;JP Kuebler;ED Crawford;I Tannock;D Raghavan;R Stuart-Harris;D Trump;LH Einhorn
Journal / Conference
ASCO 9:132(#511)
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8594

Analysis of MDR1 gene expression in clinical tumor samples by polymerase chain reaction (PCR).

Authors
KE Noonan;C Beck;TA Holzmeyer;J Wunder;I Andrulis;C Willman;B Griffith;DD Von Hoff;IB Roninson
Journal / Conference
AACR 31:361(#2140)
Year
1990
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

Expression of the EVI-1 gene encoding a DNA-binding protein in AMLs with karyotypic abnormalities of chromosome 3q.

Authors
M Whittaker;K Morishita;C Willman;T McConnell;J Lewis;J Ihle
Journal / Conference
Laboratory Investigation/Modern Pathology 62:106a
Year
1990
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750

Lack of benefit for prophylactic cranial irradiation (PCI) for patients (PTS) with small cell lung cancer (SCCL) treated with an intensive, multidrug, weekly treatment program.

Authors
S Williamson;C Taylor;J Crowley;S Taylor;T Miller;P Giri
Journal / Conference
ASCO 9:247(#955)
Year
1990
Research Committee(s)
Lung
Study Number(s)
SWOG-8606

An intergroup (SWOG & CALGB) phase III randomized study of doxorubicin & dacarbazine with or without ifosfamide & mesna in advanced soft tissue & bone sarcomas.

Authors
K Antman;L Baker;S Balcerzak;J Crowley
Journal / Conference
ASCO 9:311(#1203)
Year
1990
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8616 (INT-0072)